Literature DB >> 6568019

Human amyloid P component: an elastase inhibitor.

J J Li, K P McAdam.   

Abstract

Amyloid deposits almost invariably contain a pentagonal-shaped protein (a so-called pentraxin), termed amyloid P component (AP), in close apposition to the amyloid fibrils. AP is also detected alongside normal elastin fibres in skin and basement membrane. In the present studies, purified human AP was shown to inhibit the activity of porcine pancreatic elastase. The inhibition of elastolytic activity was not abolished by heating AP to 70 degrees C. Furthermore, two other human serum proteins used as controls did not inhibit elastase activity: albumin, which has a similarly acidic pI, and C-reactive protein, which is a pentraxin, sharing 50% sequence homology with AP. Enzyme kinetic studies showed that elastase treated with AP had a slower elastolytic rate than untreated elastase. The inhibitory effect of AP was reversed by high substrate (fivefold) concentration. These observations suggest that AP may function in vivo to protect elastin and amyloid fibrils from proteolytic cleavage. Indeed, this may in part account for the relative resistance of amyloid deposits to resorption and proteolysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6568019     DOI: 10.1111/j.1365-3083.1984.tb00995.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  8 in total

1.  Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin.

Authors:  J M Rozemuller; J J Abbink; A M Kamp; F C Stam; C E Hack; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Studies in vivo and in vitro of serum amyloid P component in normals and in a patient with AA amyloidosis.

Authors:  P N Hawkins; G A Tennent; P Woo; M B Pepys
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

3.  Antibodies to non-beta regions of the beta-amyloid precursor protein detect a subset of senile plaques.

Authors:  C Joachim; D Games; J Morris; P Ward; D Frenkel; D Selkoe
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

4.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

Authors:  G A Tennent; L B Lovat; M B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

5.  IL-1 and IL-6 mediate increased production and synthesis by hepatocytes of acute-phase reactant mouse serum amyloid P-component (SAP).

Authors:  B F Lin; N O Ku; K Zahedi; A S Whitehead; R F Mortensen
Journal:  Inflammation       Date:  1990-06       Impact factor: 4.092

6.  Tissue factor antigen in senile plaques of Alzheimer's disease.

Authors:  R D McComb; K A Miller; S D Carson
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

7.  Characterization of the gene encoding mouse serum amyloid P component. Comparison with genes encoding other pentraxins.

Authors:  A S Whitehead; M Rits
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

8.  Serum amyloid P deposition is a sensitive and specific feature of membranous-like glomerulopathy with masked IgG kappa deposits.

Authors:  Christopher P Larsen; Shree G Sharma; Tiffany N Caza; Daniel J Kenan; Aaron J Storey; Ricky D Edmondson; Christian Herzog; John M Arthur
Journal:  Kidney Int       Date:  2019-11-09       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.